HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metronomic scheduling of a cyclic hexapeptide Ra-VII for anti-angiogenesis, tumor vessel maturation and anti-tumor activity.

Abstract
RA-VII, a cyclic hexapeptide isolated from Rubiae radix, binds to actin, causing a conformational change in the actin molecule and inducing G2 arrest by inhibiting cytokinesis. Here we examined the effect of RA-VII, its water-soluble derivative, and related RA-III and RA-V on endothelial cells. Among the four compounds tested, RA-VII most potently inhibited angiogenesis-related properties of endothelial cells (i.e. migration and proliferation) in vitro. We confirmed the anti-angiogenic activity of RA-VII in vivo by using a mouse corneal model. We then applied RA-VII for the treatment of tumors in mice. Daily intraperitoneal injection of RA-VII (1.5 or 3 mg/kg/day) exhibited no toxic effect on the animals, but significantly and dose dependently inhibited the growth of Lewis lung carcinoma cells previously inoculated into the mice. Interestingly, although two doses of RA-VII decreased the tumor vascular area to a similar extent, a higher dose of RA-VII led to tumor vessel maturation together with a significant increase in tumor cell apoptosis. Also, RA-VII showed a cytotoxic effect on Lewis lung carcinoma cells. These results indicate that metronomic scheduling of RA-VII is efficient for cancer treatment. A careful dose setting of RA-VII is crucial to obtain therapeutic superiority, possibly through tumor vessel maturation and a better distribution of the compound in the tumor tissue.
AuthorsTakayuki Koizumi, Mayumi Abe, Tohru Yamakuni, Yasushi Ohizumi, Yukio Hitotsuyanagi, Koichi Takeya, Yasufumi Sato
JournalCancer science (Cancer Sci) Vol. 97 Issue 7 Pg. 665-74 (Jul 2006) ISSN: 1347-9032 [Print] England
PMID16827808 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Peptides, Cyclic
  • RA III peptide, Rubiae radix
  • RA V
  • RA VII
Topics
  • Animals
  • Blood Vessels (cytology, drug effects, growth & development)
  • Carcinoma, Lewis Lung (blood supply, drug therapy)
  • Cattle
  • Cell Movement (drug effects)
  • Cell Proliferation (drug effects)
  • Endothelial Cells (drug effects)
  • Mice
  • Neovascularization, Pathologic (drug therapy)
  • Peptides, Cyclic (administration & dosage, pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: